251 related articles for article (PubMed ID: 28223412)
1. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.
Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ
Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a 1,3,4-oxadiazole series for inhibition of Ca
Kaur J; Soto-Velasquez M; Ding Z; Ghanbarpour A; Lill MA; van Rijn RM; Watts VJ; Flaherty DP
Eur J Med Chem; 2019 Jan; 162():568-585. PubMed ID: 30472604
[TBL] [Abstract][Full Text] [Related]
3. A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing Tolerance.
Giacoletti G; Price T; Hoelz LVB; Shremo Msdi A; Cossin S; Vazquez-Falto K; Amorim Fernandes TV; Santos de Pontes V; Wang H; Boechat N; Nornoo A; Brust TF
Front Pharmacol; 2022; 13():935588. PubMed ID: 35899113
[TBL] [Abstract][Full Text] [Related]
4. A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.
Soto-Velasquez M; Hayes MP; Alpsoy A; Dykhuizen EC; Watts VJ
Mol Pharmacol; 2018 Sep; 94(3):963-972. PubMed ID: 29950405
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl cyclases.
Vadakkan KI; Wang H; Ko SW; Zastepa E; Petrovic MJ; Sluka KA; Zhuo M
Mol Pain; 2006 Feb; 2():7. PubMed ID: 16503978
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of the adenylyl cyclase inhibitor ST034307 on tooth-movement-induced nociception in rats.
Cheng Y; Huang P; Meng B; Gan L; Wu D; Cao Y
Arch Oral Biol; 2019 Feb; 98():81-86. PubMed ID: 30465937
[TBL] [Abstract][Full Text] [Related]
7. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases.
Wei F; Qiu CS; Kim SJ; Muglia L; Maas JW; Pineda VV; Xu HM; Chen ZF; Storm DR; Muglia LJ; Zhuo M
Neuron; 2002 Nov; 36(4):713-26. PubMed ID: 12441059
[TBL] [Abstract][Full Text] [Related]
8. Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin-Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin.
Hayes MP; Soto-Velasquez M; Fowler CA; Watts VJ; Roman DL
ACS Chem Neurosci; 2018 Feb; 9(2):346-357. PubMed ID: 28968502
[TBL] [Abstract][Full Text] [Related]
9. Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor.
Lübker C; Seifert R
PLoS One; 2015; 10(5):e0124017. PubMed ID: 25946093
[TBL] [Abstract][Full Text] [Related]
10. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Small Interfering RNA Screening Reveals a Role for Cullin3-Really Interesting New Gene Ligase Signaling in Heterologous Sensitization of Adenylyl Cyclase.
Ding Z; Ejendal KFK; Soto-Velasquez M; Hayes MP; Santoro N; Larsen MJ; Watts VJ
J Pharmacol Exp Ther; 2020 Mar; 372(3):267-276. PubMed ID: 31857349
[TBL] [Abstract][Full Text] [Related]
12. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.
Brand CS; Hocker HJ; Gorfe AA; Cavasotto CN; Dessauer CW
J Pharmacol Exp Ther; 2013 Nov; 347(2):265-75. PubMed ID: 24006339
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium-stimulated adenylyl cyclase subtype 1 (AC1) for the treatment of neuropathic and inflammatory pain in adult female mice.
Zhou Z; Shi W; Fan K; Xue M; Zhou S; Chen QY; Lu JS; Li XH; Zhuo M
Mol Pain; 2021; 17():17448069211021698. PubMed ID: 34082635
[TBL] [Abstract][Full Text] [Related]
14. Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain.
Wang H; Xu H; Wu LJ; Kim SS; Chen T; Koga K; Descalzi G; Gong B; Vadakkan KI; Zhang X; Kaang BK; Zhuo M
Sci Transl Med; 2011 Jan; 3(65):65ra3. PubMed ID: 21228397
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V.
Watts VJ; Taussig R; Neve RL; Neve KA
Mol Pharmacol; 2001 Dec; 60(6):1168-72. PubMed ID: 11723222
[TBL] [Abstract][Full Text] [Related]
16. The type 8 adenylyl cyclase is critical for Ca2+ stimulation of cAMP accumulation in mouse parotid acini.
Watson EL; Jacobson KL; Singh JC; Idzerda R; Ott SM; DiJulio DH; Wong ST; Storm DR
J Biol Chem; 2000 May; 275(19):14691-9. PubMed ID: 10799557
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Opioid-Mediated Adenylyl Cyclase Inhibition in Live Cells Using a BRET-Based Assay.
Manandhar P; Sachdev S; Santiago M
Methods Mol Biol; 2021; 2201():117-125. PubMed ID: 32975794
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.
Erdorf M; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Apr; 383(4):357-72. PubMed ID: 21279330
[TBL] [Abstract][Full Text] [Related]
19. Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells.
Quinn SN; Graves SH; Dains-McGahee C; Friedman EM; Hassan H; Witkowski P; Sabbatini ME
Mol Carcinog; 2017 Apr; 56(4):1344-1360. PubMed ID: 27891679
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a Pyrimidinone Series for Selective Inhibition of Ca
Scott JA; Soto-Velasquez M; Hayes MP; LaVigne JE; Miller HR; Kaur J; Ejendal KFK; Watts VJ; Flaherty DP
J Med Chem; 2022 Mar; 65(6):4667-4686. PubMed ID: 35271288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
